Does Online Buprenorphine Training Work? Evaluating Effectiveness and Learner Satisfaction of BuprenorphineCME.com

Tanner TB, Coulehan M, Metcalf MP. Does Online Buprenorphine Training Work? Evaluating Effectiveness and Learner Satisfaction of BuprenorphineCME.com. Presented for ASAM 40th Annual Medical-Scientific Conference. 05/01/2009

Abstract: Read full abstract

Introduction: To deliver buprenorphine training to a larger number of physicians, we developed an Internet-based buprenorphine training program consisting of 12 online continuing medical education (CME) modules organized into 8 hours of learning. Education could be completed in any order and at the learner's convenience. In total, 1180 learners completed the program between April 2007 and April 2009; 95% were physicians.

Methodology: For each course, learners completed pre- and post-test measures on knowledge about substance abuse and treatment, attitudes toward treating addiction, intended behavior toward addicted patients, self-efficacy in understanding and treating addiction, and satisfaction with the learning experience. For analysis purposes, knowledge post-tests recorded only the learners' first answers to each question. The data reported here was collected from April - October 2008 (n=243).

Results: Data analysis revealed that the mean scores increased from the pre- to post-test in 12/12 courses for all outcomes measured: knowledge, attitude, intended behavior, and self-efficacy (p< .0001 for each outcome). Of learners who completed the optional post-training satisfaction survey (n= 243), 89.7% agreed/strongly agreed that the training program was a valuable learning experience and 95% said that they had colleagues who could benefit from the program. Convenience, organization, and availability of the online program were strong assets.

Conclusion: Online training on buprenphine is well received and effective. The value of online training to other topics and for alternative audiences should be studied further.

Disclaimer/Funding: The training program was developed with funding from NIDA (#R44DA12066) and is supported by ASAM as a DATA-qualifying buprenorphine training program.










PDFs: